The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-(4-amino-1H-imidazol-1-yl)-2-(4-fluorophenyl)-1-(pyrrolidin-1-yl)propan-1-one ID: ALA3527046
PubChem CID: 118753229
Max Phase: Preclinical
Molecular Formula: C16H19FN4O
Molecular Weight: 302.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@](C(=O)N1CCCC1)(c1ccc(F)cc1)n1cnc(N)c1
Standard InChI: InChI=1S/C16H19FN4O/c1-16(21-10-14(18)19-11-21,12-4-6-13(17)7-5-12)15(22)20-8-2-3-9-20/h4-7,10-11H,2-3,8-9,18H2,1H3/t16-/m1/s1
Standard InChI Key: HAMLHDLTXOXVBD-MRXNPFEDSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
3.8693 -16.6899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0792 -17.9415 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.0696 -17.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9832 -16.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7893 -13.5330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3230 -14.6936 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7639 -16.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6821 -14.5212 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5327 -15.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0176 -15.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3883 -17.3575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5633 -17.2734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8381 -15.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8751 -14.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0749 -13.1205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3159 -17.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2277 -16.5188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1737 -16.1147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7125 -15.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0946 -13.8066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5425 -13.1936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1899 -15.2706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 20 1 0
10 13 1 0
20 21 2 0
8 10 1 0
18 7 1 0
10 9 1 0
7 16 1 0
9 19 2 0
3 4 1 0
14 8 1 0
17 12 2 0
13 6 2 0
13 18 1 0
16 3 1 0
10 22 1 6
5 14 2 0
12 2 1 0
21 5 1 0
1 9 1 0
19 17 1 0
12 11 1 0
4 18 1 0
11 1 2 0
15 5 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 302.35Molecular Weight (Monoisotopic): 302.1543AlogP: 1.99#Rotatable Bonds: 3Polar Surface Area: 64.15Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.64CX LogP: 1.88CX LogD: 1.82Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.94Np Likeness Score: -0.92
References 1. Borel AG, Jones TM, Barbuch RJ, Jackson DA, Kulanthaivel P, Mattiuz E, Klimkowski VJ, Wheeler WJ, Rener GA.. (2011) Metabolism of LY654322, a growth hormone secretagogue, to an unusual diimidazopyridine metabolite., 39 (5): [PMID:21346003 ] [10.1124/dmd.110.037598 ]